Post-approval studies (Phase 4)Looking for participantsNCT04073290
What this trial is testing
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Who this might be right for
Hepatic EncephalopathyCirrhosis, LiverPortal Hypertension+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 238